Quick Answer
enVVeno Medical Corp reported R&D Expense of $9.98 million for fiscal year 2025.
enVVeno Medical Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.98M | -18.5% |
| 2024 | $12.25M | -9.8% |
| 2023 | $13.58M | +37.0% |
| 2022 | $9.91M | +73.1% |
| 2021 | $5.73M | +34.7% |
| 2020 | $4.25M | +92.7% |
| 2019 | $2.21M | +78.1% |
| 2018 | $1.24M | +90.7% |
| 2017 | $649.7K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.58M | -9.6% | -10.6% |
| June 30, 2025 | $2.89M | +2.3% | +13.1% |
| March 31, 2025 | $2.56M | -16.2% | -10.6% |
| September 30, 2024 | $2.86M | +2.2% | +1.2% |
| June 30, 2024 | $2.83M | -33.0% | -7.4% |
| March 31, 2024 | $3.05M | -15.1% | +9.1% |
| September 30, 2023 | $2.80M | +12.3% | -33.6% |
| June 30, 2023 | $4.21M | +37.1% | +17.2% |
- enVVeno Medical Corp showed a decrease of -18.5% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, enVVeno Medical Corp’s r&d expense has grown by 1436.2% (from $649.7 thousand to $9.98 million).
- The most recent figure is from enVVeno Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: